BlackRock, Inc. (BLK) 13D/13G Filings for Anika Therapeutics, Inc. (ANIK)

BlackRock, Inc. 13D and 13G filings for Anika Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-08
2:17 pm
Unchanged
2024-09-3013GAnika Therapeutics, Inc.
ANIK
BlackRock Inc.
BLK
1,764,607
11.900%
0
(Unchanged)
Filing
2024-10-23
5:04 pm
Purchase
2024-09-3013GAnika Therapeutics, Inc.
ANIK
BlackRock Inc.
BLK
1,764,607
11.900%
203,495increase
(+13.04%)
Filing
2024-04-05
12:21 pm
Purchase
2024-03-3113GAnika Therapeutics, Inc.
ANIK
BlackRock Inc.
BLK
1,561,112
10.700%
177,235increase
(+12.81%)
Filing
2024-01-24
2:27 pm
Sale
2023-12-3113GAnika Therapeutics, Inc.
ANIK
BlackRock Inc.
BLK
1,383,877
9.500%
-32,258decrease
(-2.28%)
Filing
2023-10-06
2:34 pm
Sale
2023-09-3013GAnika Therapeutics, Inc.
ANIK
BlackRock Inc.
BLK
1,416,135
9.700%
-1,110,667decrease
(-43.96%)
Filing
2023-01-26
08:52 am
Unchanged
2022-12-3113GAnika Therapeutics, Inc.
ANIK
BlackRock Inc.
BLK
2,526,802
17.300%
0
(Unchanged)
Filing
2023-01-20
09:43 am
Purchase
2022-12-3113GAnika Therapeutics, Inc.
ANIK
BlackRock Inc.
BLK
2,526,802
17.300%
168,185increase
(+7.13%)
Filing
2022-01-27
1:59 pm
Unchanged
2021-12-3113GAnika Therapeutics, Inc.
ANIK
BlackRock Inc.
BLK
2,358,617
16.300%
0
(Unchanged)
Filing
2022-01-25
6:45 pm
Purchase
2021-12-3113GAnika Therapeutics, Inc.
ANIK
BlackRock Inc.
BLK
2,358,617
16.300%
108,327increase
(+4.81%)
Filing
2021-01-25
4:56 pm
Purchase
2020-12-3113GAnika Therapeutics, Inc.
ANIK
BlackRock Inc.
BLK
2,250,290
15.800%
123,041increase
(+5.78%)
Filing
2020-02-04
11:53 am
Purchase
2019-12-3113GAnika Therapeutics, Inc.
ANIK
BlackRock Inc.
BLK
2,127,249
14.900%
14,200increase
(+0.67%)
Filing